O'Shaughnessy Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$71.3M Sell
564,610
-80,622
-12% -$10.6M 0.33% 59
2026
Q1
$89.9M Buy
645,232
+38,154
+6% +$5.34M 0.45% 37
2025
Q4
$74.5M Buy
607,078
+49,568
+9% +$6.02M 0.41% 41
2025
Q3
$61.9M Buy
557,510
+61,958
+13% +$7.04M 0.36% 52
2025
Q2
$54.9M Buy
495,552
+79,641
+19% +$8.48M 0.37% 51
2025
Q1
$46.6M Buy
415,911
+98,609
+31% +$10.2M 0.37% 51
2024
Q4
$29.3M Buy
317,302
+110,056
+53% +$9.91M 0.25% 78
2024
Q3
$17.6M Buy
207,246
+55,001
+36% +$4.2M 0.16% 147
2024
Q2
$10.4M Sell
152,245
-66,303
-30% -$4.42M 0.11% 207
2024
Q1
$16M Sell
218,548
-4,803
-2% -$369K 0.18% 125
2023
Q4
$18.1M Buy
223,351
+2,502
+1% +$195K 0.24% 98
2023
Q3
$16.6M Buy
220,849
+32,790
+17% +$2.52M 0.25% 108
2023
Q2
$14.5M Sell
188,059
-28,784
-13% -$2.3M 0.22% 123
2023
Q1
$18M Buy
216,843
+15,633
+8% +$1.29M 0.28% 99
2022
Q4
$17.3M Buy
201,210
+81,041
+67% +$6.42M 0.28% 102
2022
Q3
$7.41M Buy
120,169
+78,983
+192% +$4.98M 0.14% 177
2022
Q2
$2.55M Buy
41,186
+7,793
+23% +$482K 0.05% 336
2022
Q1
$1.99M Sell
33,393
-59,262
-64% -$3.79M 0.03% 400
2021
Q4
$6.73M Buy
92,655
+3,336
+4% +$230K 0.12% 192
2021
Q3
$6.24M Buy
89,319
+18,731
+27% +$1.32M 0.13% 163
2021
Q2
$4.86M Buy
70,588
+11,405
+19% +$762K 0.1% 189
2021
Q1
$3.83M Buy
59,183
+53,876
+1,015% +$3.47M 0.08% 186
2020
Q4
$309K Buy
5,307
+264
+5% +$15.9K 0.01% 681
2020
Q3
$319K Sell
5,043
-3,617
-42% -$251K 0.01% 567
2020
Q2
$666K Buy
8,660
+6,557
+312% +$503K 0.02% 347
2020
Q1
$157K Buy
2,103
+384
+22% +$26.5K 0.01% 533
2019
Q4
$112K Buy
1,719
+1,711
+21,388% +$111K ﹤0.01% 760
2019
Q3
$1K Buy
8
+6
+300% +$392 ﹤0.01% 903
2019
Q2
$0 Buy
+2
New +$132 ﹤0.01% 1063
2019
Q1
Sell
-52,650
Closed -$3.29M 943
2018
Q4
$3.29M Sell
52,650
-86,259
-62% -$6.03M 0.08% 143
2018
Q3
$10.7M Sell
138,909
-105,500
-43% -$7.97M 0.22% 85
2018
Q2
$17.3M Sell
244,409
-358,304
-59% -$25.3M 0.37% 61
2018
Q1
$45.4M Sell
602,713
-284,240
-32% -$22.6M 0.99% 29
2017
Q4
$63.5M Sell
886,953
-335,277
-27% -$25.5M 1.48% 17
2017
Q3
$99M Sell
1,222,230
-96,648
-7% -$7.39M 2.3% 7
2017
Q2
$93.3M Buy
1,318,878
+168,958
+15% +$11.2M 2.19% 11
2017
Q1
$78.1M Buy
1,149,920
+427,507
+59% +$30.1M 1.84% 11
2016
Q4
$51.7M Buy
722,413
+320,877
+80% +$23.9M 1.22% 24
2016
Q3
$31.8M Buy
401,536
+259,426
+183% +$21.1M 0.74% 40
2016
Q2
$10.4M Buy
142,110
+142,062
+295,963% +$12.6M 0.27% 84
2016
Q1
$4K Sell
48
-46
-49% -$4.15K ﹤0.01% 838
2015
Q4
$10K Sell
94
-26,004
-100% -$2.71M ﹤0.01% 731
2015
Q3
$2.56M Sell
26,098
-12,727
-33% -$1.41M 0.05% 208
2015
Q2
$4.55M Sell
38,825
-3,543
-8% -$387K 0.09% 156
2015
Q1
$4.16M Sell
42,368
-2,515
-6% -$255K 0.08% 161
2014
Q4
$4.23M Buy
44,883
+1,487
+3% +$154K 0.08% 169
2014
Q3
$4.62M Sell
43,396
-28,456
-40% -$2.79M 0.08% 169
2014
Q2
$5.96M Sell
71,852
-3,274
-4% -$255K 0.11% 144
2014
Q1
$5.32M Buy
75,126
+3,566
+5% +$280K 0.11% 145
2013
Q4
$5.38M Buy
71,560
+14,261
+25% +$993K 0.11% 141
2013
Q3
$3.6M Buy
57,299
+51,291
+854% +$3.07M 0.09% 165
2013
Q2
$308K Buy
+6,008
New +$313K 0.01% 467

Other funds holding GILD

O'Shaughnessy Asset Management's GILD Position: Q2 2026 in Review

O'Shaughnessy Asset Management reduced its Gilead Sciences (GILD) stake by 12% in Q2 2026, selling an estimated $10.6M and leaving 564,610 shares worth $71.3M. The position accounts for 0.33% of the portfolio, ranked #59.

O'Shaughnessy Asset Management first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $99M in Q3 2017. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • O'Shaughnessy Asset Management held 564,610 shares of Gilead Sciences worth $71.3M as of Q2 2026.
  • O'Shaughnessy Asset Management sold 80,622 Gilead Sciences shares in Q2 2026, an estimated $10.6M.
  • Gilead Sciences made up 0.33% of O'Shaughnessy Asset Management's portfolio in Q2 2026, its #59 holding.
  • O'Shaughnessy Asset Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • O'Shaughnessy Asset Management's Gilead Sciences position peaked at $99M in Q3 2017.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.